JAMA

Journal · General medicine · Updated 13 November 2026

JAMA

Read JAMA research on DeepDyve the week it’s published, plus decades of back issues. No hospital or university library needed.

JAMA, the journal of the American Medical Association, has been published since 1883 and now puts out 48 issues a year: clinical trials, reviews and commentary from across medicine. A DeepDyve subscription lets you read it in full, alongside millions of articles from other journals licensed from publishers including JAMA.

Then $59 a month or $499 a year. A credit card is required; cancel during the trial and you won’t be charged. You read articles online; PDFs are sold separately. Personal plans aren’t for business use: reading for work? See Enterprise.

Medical illustration of the human brain and its arteries, from JAMA Network
Image: JAMA Network

JAMA at a glance

Full title
JAMA
Former title (until 1960)
Journal of the American Medical Association
Abbreviation (ISO 4 and NLM)
JAMA
Former NLM abbreviation
J Am Med Assoc
Publisher
American Medical Association
Print ISSN
0098-7484
Online ISSN (eISSN)
1538-3598
Earlier ISSN (until 1960)
0002-9955
First published
1883
Frequency
48 issues a year
Editor in Chief
Kirsten Bibbins-Domingo
Subjects
General medicine and public health
Access model
Subscription; research articles free on JAMA’s website 6 months after publication
On DeepDyve
Current and back issues; availability varies by article

Ways to access JAMA

JAMA research articles become free on JAMA’s website 6 months after publication. For newer research, look for the authors’ manuscript, use a library, or read it on DeepDyve.

  1. Free on JAMA’s website after 6 months. All JAMA research articles are free to read on jamanetwork.com 6 months after publication, and JAMA deposits them in PubMed Central.
  2. The authors’ accepted manuscript. Since 2023, JAMA Network has let authors post the accepted manuscript of original research in a repository on the day of publication. Search the title in PubMed Central, Google Scholar or the authors’ university repository.
  3. NIH-funded research. For papers accepted on or after July 1, 2025, the US National Institutes of Health requires the accepted manuscript in PubMed Central, free with no embargo from the official publication date.
  4. A library. Hospital and university libraries, and some public libraries, subscribe to JAMA. Check your library’s journal list and whether it offers remote access.
  5. DeepDyve. Read JAMA research online the week it’s published, plus back issues, for $59 a month or $499 a year after a free first month. Articles marked LitStream below are in DeepDyve’s LitStream collection, which a subscription lets you read online. PDFs are sold separately, and availability varies by article.

Sources: About JAMA; AMA on JAMA Network’s manuscript policy; NIH Public Access Policy.

This week’s issue · Volume 336, Number 18 · November 10, 2026

In this issue: a stroke drug trial and a new way to rank heart transplant candidates

A randomized trial tests whether intravenous loberamisal improves recovery after acute ischemic stroke, and a cohort study compares a medical urgency score for allocating donor hearts with the current US system.

Read the stroke trial · Read the heart allocation study

Recent JAMA research worth reading

Published October and November 2026. Summaries describe what the authors report.

  1. LitStreamSleep medicine · Obesity

    Orforglipron for Obstructive Sleep Apnea

    In two trials of adults with obesity or overweight and moderate to severe sleep apnea, the authors report that the once-daily pill orforglipron reduced breathing interruptions during sleep more than placebo, whether or not patients also used positive airway pressure.

    Malhotra et al. · JAMA, published online November 9, 2026 · DOI 10.1001/jama.2026.24080

  2. LitStreamDigital health · AI

    Clinician Use of an Artificial Intelligence–Enabled Clinical Information Platform

    Looking at 271 million queries from about 950,000 US clinicians over two and a half years, the authors report that clinicians used an AI clinical information platform mainly for treatment and management decisions rather than diagnosis.

    Patel et al. · JAMA, published online October 15, 2026 · DOI 10.1001/jama.2026.21868

  3. LitStreamHypertension · Global health

    Implementation of Single-Pill Combination Therapy Through Team-Based Care for Hypertension Control

    In 40 primary care clinics in Colombia and Jamaica, the authors report that a single combination blood pressure pill, given through team-based care, lowered systolic pressure by 10 mm Hg over 18 months compared with standard treatment.

    Lopez-Lopez et al. · JAMA, published online November 8, 2026 · DOI 10.1001/jama.2026.24169

  4. LitStreamCritical care

    Effect of Vasopressin Initiation Threshold on Septic Shock Mortality

    Across 13 hospitals and nearly 4,000 patients with septic shock, the authors report that a strategy of starting vasopressin earlier did not lower 28-day mortality.

    Peltan et al. · JAMA, published online October 14, 2026 · DOI 10.1001/jama.2026.21333

  5. LitStreamCardiology

    Low-Voltage Area Ablation for Persistent Atrial Fibrillation

    In 508 patients with persistent atrial fibrillation, adding ablation of low-voltage heart tissue to standard pulmonary vein isolation did not improve outcomes overall, though the authors report results consistent with a possible benefit for patients who had such tissue.

    Nery et al. · JAMA, published online November 8, 2026 · DOI 10.1001/jama.2026.24331

  6. LitStreamCardiology

    Antithrombotic Therapy After Left Atrial Appendage Occlusion

    In 1,857 patients after left atrial appendage closure, the authors report that reduced-dose anticoagulants or aspirin alone were noninferior to dual antiplatelet therapy for death, stroke, embolism or major bleeding at six months.

    Reddy et al. · JAMA, published online November 2, 2026 · DOI 10.1001/jama.2026.21361

  7. LitStreamOncology · Breast cancer

    Trastuzumab Rezetecan in ERBB2-Low Advanced Breast Cancer

    The authors report that trastuzumab rezetecan improved progression-free survival compared with chemotherapy in advanced ERBB2-low (HER2-low) breast cancer, including in hormone receptor–negative disease.

    Fan et al. · JAMA, published online October 23, 2026 · DOI 10.1001/jama.2026.21372

See every JAMA article on DeepDyve

Landmark JAMA papers you can read

Questions about JAMA

How can I read JAMA articles without a subscription?

JAMA research articles are free on JAMA’s website 6 months after publication, and JAMA deposits them in PubMed Central. For newer research, look for the authors’ accepted manuscript in PubMed Central or a university repository, or check whether your hospital, university or public library subscribes. DeepDyve also lets you read JAMA research the week it’s published, for $59 a month or $499 a year after a free first month.

What is the abbreviation for JAMA?

JAMA is the journal’s full title, so its ISO 4 and NLM (PubMed) abbreviation is simply JAMA. Before 1960 it was the Journal of the American Medical Association, abbreviated J Am Med Assoc in NLM records. A current reference reads, for example, JAMA. 2026;336(18):1621-1629.

What does JAMA stand for?

JAMA started as the Journal of the American Medical Association. It took the JAMA title in 1960 and is published by the American Medical Association.

What is the ISSN of JAMA?

The print ISSN is 0098-7484 and the online ISSN is 1538-3598. Before 1960, as the Journal of the American Medical Association, it used ISSN 0002-9955.

Is JAMA open access?

No. JAMA is a subscription journal. It makes its research articles free to read on its website 6 months after publication and deposits them in PubMed Central.

JAMA articles on DeepDyve are licensed from the American Medical Association. Journal facts as of 13 November 2026.

Start reading JAMA today

One month free, then less than $2 a day. JAMA, plus millions of articles from thousands of journals.

Start free month